Filing Details

Accession Number:
0001140361-17-026278
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-27 16:57:09
Reporting Period:
2017-06-26
Filing Date:
2017-06-27
Accepted Time:
2017-06-27 16:57:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184126 W Frederick Gluck 743 San Ysidro Road
Santa Barbara CA 91308
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-06-26 5,000 $14.61 326,643 No 4 S Indirect By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 22,111 Indirect By Richlin Partners, LLC
Common Stock 3,200 Indirect By spouse
Footnotes
  1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.38 to $14.84, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
  4. Richlin Partners, LLC is an entity owned of record by the spouse of the Reporting Person.